These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24975823)

  • 1. A quantitative and humane tail bleeding assay for efficacy evaluation of antihaemophilic factors in haemophilia A mice.
    Molina ES; Fujita A; Sogayar MC; Demasi MA
    Haemophilia; 2014 Nov; 20(6):e392-8. PubMed ID: 24975823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive venous bleeding model in haemophilia A mice: effects of two recombinant FVIII products (N8 and Advate(®)).
    Pastoft AE; Lykkesfeldt J; Ezban M; Tranholm M; Whinna HC; Lauritzen B
    Haemophilia; 2012 Sep; 18(5):782-8. PubMed ID: 22500820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII efficient and specific non-covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy.
    Baru M; Carmel-Goren L; Barenholz Y; Dayan I; Ostropolets S; Slepoy I; Gvirtzer N; Fukson V; Spira J
    Thromb Haemost; 2005 Jun; 93(6):1061-8. PubMed ID: 15968389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ferric chloride induced arterial injury model used as haemostatic effect model.
    Møller F; Tranholm M
    Haemophilia; 2010 Jan; 16(1):e216-22. PubMed ID: 19878330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice - characterization of two novel FVIII molecules.
    Johansen PB; Tranholm M; Haaning J; Knudsen T
    Haemophilia; 2016 Jul; 22(4):625-31. PubMed ID: 26936336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bleeding times in haemophilia patients treated with lyophilised antihaemophilic globulin (AHG) (author's transl)].
    Sutor AH; Jesdinsky-Buscher CJ
    Dtsch Med Wochenschr; 1976 Nov; 101(47):1715-9. PubMed ID: 991757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of the haemostatic plugs of dogs with haemophilia A (factor VIII deficiency) following the infusion of a combination of factor Xa and phosphatidylcholine/phosphatidylserine vesicles.
    Hong yu Ni; Giles AR
    Thromb Haemost; 1992 Feb; 67(2):264-71. PubMed ID: 1621248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents.
    Stagaard R; Flick MJ; Bojko B; Goryński K; Goryńska PZ; Ley CD; Olsen LH; Knudsen T
    J Thromb Haemost; 2018 Jul; 16(7):1369-1382. PubMed ID: 29758126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of factor VII in haemostasis: infusion studies of factor VIIa in a canine model of factor VIII deficiency.
    Mertens K; Briët E; Giles AR
    Thromb Haemost; 1990 Aug; 64(1):138-44. PubMed ID: 2274919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the haemostatic potential of factor VIII-heparin cofactor II hybrid proteins in a mouse model.
    Schatz S; Turecek PL; Fiedler C; Zimmermann K; Gritsch H; Voorberg J; Schwarz HP; Dorner F; Scheiflinger F
    Br J Haematol; 2003 Nov; 123(4):692-5. PubMed ID: 14616974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.
    Pabinger I; Mamonov V; Windyga J; Engl W; Doralt J; Tangada S; Spotts G; Ewenstein B
    Haemophilia; 2021 May; 27(3):e331-e339. PubMed ID: 33772963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative measure of the efficacy of factor VIII in hemophilia A mice.
    Parker ET; Lollar P
    Thromb Haemost; 2003 Mar; 89(3):480-5. PubMed ID: 12624631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged effect of a new O-glycoPEGylated FVIII (N8-GP) in a murine saphenous vein bleeding model.
    Pastoft AE; Ezban M; Tranholm M; Lykkesfeldt J; Lauritzen B
    Haemophilia; 2013 Nov; 19(6):913-9. PubMed ID: 23730746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of haemostatic efficacy of plasma-derived FVIII by formulation with PEGylated liposomes.
    Dayan I; Robinson M; Baru M
    Haemophilia; 2009 Sep; 15(5):1006-13. PubMed ID: 19486171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New assays for monitoring haemophilia treatment.
    Shima M; Matsumoto T; Ogiwara K
    Haemophilia; 2008 Jul; 14 Suppl 3():83-92. PubMed ID: 18510527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild haemophilia: a disease with many faces and many unexpected pitfalls.
    Peerlinck K; Jacquemin M
    Haemophilia; 2010 Jul; 16 Suppl 5():100-6. PubMed ID: 20590864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of antihaemophilic factor using the prothrombin conversion ratio.
    WOLF P
    Br J Haematol; 1956 Oct; 2(4):386-96. PubMed ID: 13383105
    [No Abstract]   [Full Text] [Related]  

  • 18. New quantitative aPTT waveform analysis and its application in laboratory management of haemophilia A patients.
    Milos M; Coen Herak D; Zupancic-Salek S; Zadro R
    Haemophilia; 2014 Nov; 20(6):898-904. PubMed ID: 25273337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
    Johansen RF; Sørensen B; Ingerslev J
    Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in the laboratory analyses of bleeding disorders.
    Chitlur M
    Thromb Res; 2012 Jul; 130(1):1-6. PubMed ID: 22483776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.